search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Endoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett’s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.


- candidate number2536
- NTR NumberNTR945
- ISRCTNISRCTN68328077
- Date ISRCTN created30-mei-2007
- date ISRCTN requested22-mei-2007
- Date Registered NTR30-mrt-2007
- Secondary IDs 
- Public TitleEndoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett’s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.
- Scientific TitleEndoscopic Tri-Modal Imaging (ETMI) for the detection of early neoplasia in patients with Barrett’s esophagus (BE) in tertiary referral centers; a randomized cross-over multi-center study.
- ACRONYMETMIC
- hypothesisETMI improves the detection of early neoplasia in Barrett's esophagus.
- Healt Condition(s) or Problem(s) studiedBarrett's esophagus, Autofuorecence imaging , Narrow band imaging
- Inclusion criteria1. Age > 18 years; 2. Prior diagnosis of BE defined as the presence of columnar lined epithelium in the tubular esophagus with specialised intestinal metaplasia on histological investigation; 3. Prior diagnosis of high-grade dysplasia or early cancer that was endoscopically inconspicuous according to the referring physician. Review of the pathology slides is not required for inclusion; 4. A minimum Barrett’s length of C>2M>2 or C<2M>4 according to the Prague C&M classification of the endoscopic appearance of BE; 4. Written informed consent.
- Exclusion criteria1. Presence of active erosive esophagitis > grade A according to the Los Angles classification of erosive esophagitis; 2. Description of an endoscopically visible suspicious lesion in the Barrett’s segment in the referring center; 3. Presence of conditions precluding histological sampling of the esophagus (e.g. esophageal varices, coagulation disorders, anticoagulant therapy); 4. At the first endoscopy: the presence of a type 0-I or type 0-III lesion or a lesion that, according to the discretion of the endoscopist, does not allow a delay in intervention for a period of 6 weeks (interval between the two cross-over endoscopies).
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingNone
- controlNot applicable
- groupCrossover
- Type-
- Studytypeintervention
- planned startdate 1-mrt-2007
- planned closingdate1-sep-2008
- Target number of participants84
- InterventionsIn this study we will compare diagnostic endoscopy techniques for the detection of early enoplasia in Barrett's esophagus. These techniques are standard video endoscopy (the current standard) and Endoscopic Tri-Modal Imaging (ETMI). Patients will undergo two consecutive endoscopies in an interval of 8-12 weeks. One of the two aformentioned techniques will be randomly assigned to the first procedure, the second procedure will subsequently be performed with the other technique by a second endoscopist. The primary outcome will be the number of lesions and patients with early neoplasia detected with standard video endoscopy and ETMI.
- Primary outcome1. The number of patients and the number of lesions with early neoplasia detected with SVE and ETMI; 2. The number of patients with early neoplasia detected with targeted biopsies only with ETMI and SVE.
- Secondary outcome1. The sensitivity and positive predictive value (PPV) of HRE and AFI; 2. The reduction of false positive findings after NBI; 3. Negative predictive value of the combination of HRE and AFI and the reduction in false negative findings after.
- Timepoints
- Trial web site
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESProf. dr. J.J.G.H.M. Bergman
- CONTACT for SCIENTIFIC QUERIESProf. dr. J.J.G.H.M. Bergman
- Sponsor/Initiator Academic Medical Center (AMC), Department of Hepato- and Gastroenterology
- Funding
(Source(s) of Monetary or Material Support)
Olympus Corp, Tokyo, Japan
- PublicationsCurvers WL, Wong Kee Song LM, Wang K, Gostout CJ, Wallace MB, Wolfsen HC, Ragunath R, Fockens P, Bergman JJ. Endoscopic Tri-Modal Imaging (ETMI) for the Detection of Dysplastic Lesions in Barrett's Esophagus; a multi-centre feasibility study. Endosc 2006; 38 (suppl II) A34.
- Brief summaryEndoscopic Trimodal Imaging is a new imaging device that incorperates high-resolution white light endoscopy with autofluorescence imaging and narrow band imaging. Our aim of this study is to compare ETMI with standard video endoscopy for the detection of early neoplastic lesions in Barrett's esophagus. In this study high-risk patients reffered for the work-up of high-grade dysplasia or early cancer will included. All prodedures will performed by expert endoscopists in this field in 4 tertiary referal centres for the endoscopic treatment of early Barrett's neoplasia. All patients will undergo two endoscopies (ETMI and SVE) perfromed by two different endoscopists with an interval of 6-12 weeks.
- Main changes (audit trail)
- RECORD30-mrt-2007 - 7-aug-2007


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl